ENSP Open Letter - Tobacco Products Directive

printer versionprinter version

Honorable Member of the European Parliament,


Tobacco is the single greatest cause of preventable death globally. Tobacco use leads most commonly to diseases affecting the heart, liver and lungs, with smoking being a major risk factor for heart attacks, strokes, chronic obstructive pulmonary disease (COPD) (including emphysema and chronic bronchitis), and cancer (particularly lung cancer, cancers of the larynx and mouth, and pancreatic cancer).

700,000 people in the EU die prematurely every year as a result of tobacco consumption!

On December 18th, 2013 an agreement was reached between the European Parliament and EU Member States on the revision of the Tobacco Products Directive. The agreement is a major achievement for tobacco control in the EU.

Now, on Wednesday February 26, 2014 the time has come to you to take decision!

ENSP - European Network for Smoking and Tobacco Prevention is kindly asking you to support and to VOTE the Directive as it stands.

This will be your true VOTE for Health in Europe!

Yours sincerely,

  

ENSP President                                               ENSP Director of Policy and Strategy

                                                                                               

Panagiotis K. Behrakis, MD,PhD,FCCP                                             Cornel Radu-Loghin

  

Pulmonologist –Intensivist

Adjunct Professor of Harvard University

Researcher of Biomedical research Foundation of Athens Academy

President of the Greek National Steering Committee on Tobacco Control

 

The two top priority objectives for ENSP are:

  

-       to have the WHO’s Framework Convention on Tobacco Control implemented in Europe by2020 and

  

-       to reduce the prevalence of tobacco use in Europe to less than 5% by 2040.

  

   

 

European Network for Smoking and Tobacco Prevention aisbl
Chaussée d'Ixelles 144 ● B-1050 Brussels
T: + 32 2 2306515 ● F: + 32 2 2307507
www.ensp.org
Follow ENSP on Facebook: https://www.facebook.com/ENSP.org


AttachmentSize
ENSP_OpenLetter TPD_26022014.pdf438.33 KB